207 related articles for article (PubMed ID: 34378540)
1. Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma.
Fan X; Deng J; Shi T; Wen H; Li J; Liang Z; Lei F; Liu D; Zhang H; Liang Y; Hao X; Wang Z
Bioorg Chem; 2021 Sep; 114():105154. PubMed ID: 34378540
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer.
Liang Z; Lei F; Deng J; Zhang H; Wang Y; Li J; Shi T; Yang X; Wang Z
Eur J Med Chem; 2022 Jan; 228():113960. PubMed ID: 34774339
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Polo-Like Kinase 1 by BI2536 Reverses the Multidrug Resistance of Human Hepatoma Cells In Vitro and In Vivo.
Li HY; Luo F; Li XY; Fu XF; He JF; Tian YZ; Zhu JJ; Chu XY; Zhao HL
Anticancer Agents Med Chem; 2019; 19(6):740-749. PubMed ID: 30836927
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells.
Sbenati RM; Zaraei SO; El-Gamal MI; Anbar HS; Tarazi H; Zoghbor MM; Mohamood NA; Khakpour MM; Zaher DM; Omar HA; Alach NN; Shehata MK; El-Gamal R
Eur J Med Chem; 2021 Jan; 210():113081. PubMed ID: 33310290
[TBL] [Abstract][Full Text] [Related]
5. Preparation of a Novel One-Armed Anti-c-Met Antibody with Antitumor Activity Against Hepatocellular Carcinoma.
Yin Y; Guo J; Teng F; Yu L; Jiang Y; Xie K; Jiang M; Fang J
Drug Des Devel Ther; 2019; 13():4173-4184. PubMed ID: 31849449
[TBL] [Abstract][Full Text] [Related]
6. Design of Evodiamine-Glucose Conjugates with Improved
Wu Z; Chen S; Chen Z; Dong G; Xu D; Sheng C
J Med Chem; 2024 May; 67(9):7373-7384. PubMed ID: 38646851
[TBL] [Abstract][Full Text] [Related]
7. Evodiamine Exerts an Anti-Hepatocellular Carcinoma Activity through a WWOX-Dependent Pathway.
Hu CY; Wu HT; Su YC; Lin CH; Chang CJ; Wu CL
Molecules; 2017 Jul; 22(7):. PubMed ID: 28708106
[TBL] [Abstract][Full Text] [Related]
8. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
[TBL] [Abstract][Full Text] [Related]
9. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.
Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL
Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900
[TBL] [Abstract][Full Text] [Related]
10. Induction of Apoptosis in Hepatocellular Carcinoma Cell Lines by Novel Indolylacrylamide Derivatives: Synthesis and Biological Evaluation.
Hawash M; Kahraman DC; Cetin-Atalay R; Baytas SN
Chem Biodivers; 2021 May; 18(5):e2001037. PubMed ID: 33713038
[TBL] [Abstract][Full Text] [Related]
11. Evodiamine Induces Apoptosis in SMMC-7721 and HepG2 Cells by Suppressing NOD1 Signal Pathway.
Guo XX; Li XP; Zhou P; Li DY; Lyu XT; Chen Y; Lyu YW; Tian K; Yuan DZ; Ran JH; Chen DL; Jiang R; Li J
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30384473
[TBL] [Abstract][Full Text] [Related]
12. Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation.
Li P; Liu Y; He Q
Drug Des Devel Ther; 2020; 14():1609-1620. PubMed ID: 32425506
[TBL] [Abstract][Full Text] [Related]
13. Chamaejasmenin E from Stellera chamaejasme induces apoptosis of hepatocellular carcinoma cells by targeting c-Met in vitro and in vivo.
Yu XQ; Yan QL; Shen S; Cheng ZY; Huang XX; Yao GD; Song SJ
Bioorg Chem; 2022 Feb; 119():105509. PubMed ID: 34844768
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma.
Zhai S; Zhang H; Chen R; Wu J; Ai D; Tao S; Cai Y; Zhang JQ; Wang L
Eur J Med Chem; 2021 Dec; 225():113824. PubMed ID: 34509167
[TBL] [Abstract][Full Text] [Related]
15. The cytotoxic and mechanistic effects of aaptamine on hepatocellular carcinoma.
Li QL; Zhang PP; Wang PQ; Yu HB; Sun F; Hu WZ; Wu WH; Zhang X; Chen F; Chu ZY; Zhang JP; Chen SS; Lin HW
Anticancer Agents Med Chem; 2015; 15(3):291-7. PubMed ID: 25403168
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of Novel Evodiamine Derivatives as Potential Antihepatocellular Carcinoma Agents.
Lei F; Xiong Y; Wang Y; Zhang H; Liang Z; Li J; Feng Y; Hao X; Wang Z
J Med Chem; 2022 Jun; 65(11):7975-7992. PubMed ID: 35639640
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor effect of evodiamine by inducing Akt-mediated apoptosis in hepatocellular carcinoma.
Yang F; Shi L; Liang T; Ji L; Zhang G; Shen Y; Zhu F; Xu L
Biochem Biophys Res Commun; 2017 Mar; 485(1):54-61. PubMed ID: 28189683
[TBL] [Abstract][Full Text] [Related]
18. Evodiamine induces apoptosis and promotes hepatocellular carcinoma cell death induced by vorinostat via downregulating HIF-1α under hypoxia.
Li YL; Zhang NY; Hu X; Chen JL; Rao MJ; Wu LW; Li QY; Zhang B; Yan W; Zhang C
Biochem Biophys Res Commun; 2018 Apr; 498(3):481-486. PubMed ID: 29505792
[TBL] [Abstract][Full Text] [Related]
19. Discovery of penipanoid C-inspired 2-(3,4,5-trimethoxybenzoyl)quinazolin-4(3H)-one derivatives as potential anticancer agents by inhibiting cell proliferation and inducing apoptosis in hepatocellular carcinoma cells.
Wang CJ; Guo X; Zhai RQ; Sun C; Xiao G; Chen J; Wei MY; Shao CL; Gu Y
Eur J Med Chem; 2021 Nov; 224():113671. PubMed ID: 34237623
[TBL] [Abstract][Full Text] [Related]
20. 6-Amino-2,4,5-trimethylpyridin-3-ol and 2-amino-4,6-dimethylpyrimidin-5-ol derivatives as selective fibroblast growth factor receptor 4 inhibitors: design, synthesis, molecular docking, and anti-hepatocellular carcinoma efficacy evaluation.
Chaudhary CL; Lim D; Chaudhary P; Guragain D; Awasthi BP; Park HD; Kim JA; Jeong BS
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):844-856. PubMed ID: 35296193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
